Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • AChE
    (1)
  • AChR
    (4)
  • Antifungal
    (1)
  • Autophagy
    (2)
  • CFTR
    (4)
  • Cysteine Protease
    (1)
  • Epigenetic Reader Domain
    (1)
  • GluR
    (4)
  • iGluR
    (2)
  • Others
    (35)
Filter
Search Result
Results for "

potentiator

" in TargetMol Product Catalog
  • Inhibitor Products
    61
    TargetMol | Activity
  • Peptides Products
    6
    TargetMol | inventory
  • Natural Products
    3
    TargetMol | natural
  • Recombinant Protein
    1
    TargetMol | composition
Bradykinin potentiator-5
T2517330505-63-6
Bradykinin potentiator-5 is a peptide inflammatory mediator, causes blood vessels to dilate (enlarge), and therefore causes blood pressure to fall.
  • Inquiry Price
Size
QTY
NMDA receptor potentiator-1
T63003486427-18-3
NMDA receptor potentiator-1 (Compound 1368) is a subunit-selective NMDA receptor enhancer with IC50 values of 4 μM and 5 μM for NR2C and NR2D expression, respectively.
  • $1,520
6-8 weeks
Size
QTY
Bradykinin potentiator C
T7650730953-20-9
Bradykinin Potentiator C, a potent inhibitor of angiotensin-converting enzyme (ACE) with an inhibitory concentration (IC 50) of 7.1 μM for rabbit lung ACE, is regarded as a prototype for functional peptides [1].
  • Inquiry Price
Size
QTY
Bradykinin potentiator B
T7650530892-86-5
Bradykinin Potentiator B (also known as Bradykinin Potentiating Peptide B), derived from the venom of Agkistrodon halys blomhoffi, serves as a potent ACE inhibitor. It effectively inhibits the activity of bradykinin inhibitory peptidase [1].
  • Inquiry Price
Size
QTY
OV-potentiator-28
T28276
OV-potentiator-28 is a potentiator of cancer virotherapy. OV-potentiator-28 significantly enhances virus replication-associated luciferase expression, specifically in tumors.
  • Inquiry Price
Size
QTY
LY450108
TQ0289376594-67-1In house
LY450108 is a potentiator of the AMPA receptor that can be used in Parkinson's disease studies.
  • $44
In Stock
Size
QTY
Chromenone 1
T613011639929-29-5In house
Chromenone 1 is a potent potentiator of osteogenic bone morphogenetic protein (BMP). Chromenone 1 induces a pronounced, kinase-independent, negative TGFβ feedback that enhances nuclear BMP-Smad signaling outputs.
  • $117
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Ivacaftor
T2588873054-44-5
Ivacaftor (VX-770) (VX-770) is a potentiator of CFTR targeting G551D-CFTR (EC50: 100 nM) and F508del-CFTR (EC50: 25 nM) in Fisher rat thyroid cells, respectively.
  • $32
In Stock
Size
QTY
TargetMol | Citations Cited
NG-012
T81676141731-76-2
NG-012, a nerve growth factor (NGF) potentiator, was isolated from the culture broth of Penicillium verruculosum F-4542. It enhances neurite outgrowth as induced by NGF in the rat pheochromocytoma cell line (PC12) [1].
  • $153
35 days
Size
QTY
TargetMol | Inhibitor Sale
SPR741
TP10901179330-52-9
SPR741, formerly NAB741 (12), is a cationic peptide derived from polymyxin B and is one such potentiator molecule that is under development for the treatment of serious Gram-negative bacterial infections.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Indiplon
T21362325715-02-4
Indiplon is a short-acting hypnotic with high-affinity allosteric potentiator of GABAA responses that demonstrates preference for alpha1 subunit-containing GABAA receptors.
    Inquiry
    TargetMol | Inhibitor Sale
    Icenticaftor
    T94991334546-77-8
    Icenticaftor (QBW251) is an orally active potentiator of CFTR channel.
    • $373
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    Dirocaftor
    T395962137932-23-9
    Dirocaftor (PTI-808) is a CFTR potentiator that augments CFTR protein function via the activation of chloride channels. Dirocaftor holds potential utility for research pertaining to cystic fibrosis (CF).
    • $1,024
    Backorder
    Size
    QTY
    TargetMol | Inhibitor Sale
    HBT1
    T8779489408-02-8
    HBT1 is an AMPA receptor potentiator that induces production of brain-derived neurotrophic factor (BDNF) and exhibits little agonistic effect in primary neurons. HBT1 binds to ligand-binding domain of AMPA-R in glutamate dependent manner.
    • $41
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    CIQ
    T14971486427-17-2
    CIQ is a subunit-selective potentiator of NMDA receptors containing the NR2C or NR2D subunit. EC50 value: 2.7 μM for NR2C and 2.8 μM for NR2D.
    • $34
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    Mip-IN-1
    T81792
    Mip-IN-1 (S,S-28i) is a novel inhibitor derived from rapamycin targeting the macrophage infectivity potentiator (Mip) proteins. It exhibits potent anti-enzymatic effects against Mip proteins from Neisseria meningitidis and Neisseria gonorrhoeae, significantly enhancing macrophage bactericidal efficacy [1].
    • Inquiry Price
    Size
    QTY
    TargetMol | Inhibitor Sale
    VU-29
    T23515890764-36-0
    VU-29 is a positive allosteric mGlu5 receptor modulator with EC50=9 nM and Ki=244 nM for rmGluR5. It is selective for mGluR5 relative to other mGluR subtypes (EC50: rmGluR1/rmGluR2=557 nM/1.5 μM; hmGluR4=154 nM).
    • $34
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    Cinepazide
    T0368L23887-46-9
    Cinepazide is a vasodilator used for the treatment of cardiovascular, cerebrovascular, and peripheral vascular diseases. Cinepazide acts as a potentiator of adenosine A2 receptors.
    • $1,520
    Backorder
    Size
    QTY
    TAK-137
    T708801358749-55-9
    TAK-137 is a novel AMPA receptor potentiator with little agonistic effect, producing antidepressant-like effect without causing psychotomimetic effects.
    • $1,520
    6-8 weeks
    Size
    QTY
    SPR741 TFA
    T75994
    SPR741 TFA (NAB741 TFA), a cationic peptide derived from polymyxin B, acts as a potentiator molecule that enhances the permeability of Gram-negative bacteria's outer membrane, thereby facilitating the treatment of severe Gram-negative bacterial infections. This compound effectively inhibits multidrug-resistant Gram-negative bacteria and, when combined with antibiotics, broadens their spectrum of activity [1] [2].
    • Inquiry Price
    Size
    QTY
    VU10010
    T23513633283-39-3
    VU10010 (VU 10010) is allosteric potentiator of M4 acetylcholine receptors.
    • $34
    In Stock
    Size
    QTY
    TG3-95-1
    T26263301322-12-3
    TG3-95-1 is an EP2 allosteric potentiator agent.
    • $1,520
    6-8 weeks
    Size
    QTY
    SPR741 TFA (1179330-52-9 free base)
    TP1089
    SPR741 TFA (NAB741 TFA) is a cationic peptide derived from polymyxin B and is a potentiator molecule.
    • Inquiry Price
    Size
    QTY
    3,3'-Difluorobenzaldazine
    T2272015332-10-2
    allosteric potentiator of mGlu5
    • $143
    35 days
    Size
    QTY
    GLPG1837
    T70831654725-02-6
    GLPG1837 (ABBV-974) is an effective CFTR potentiator, with EC50s of 3 nM and 339 nM for F508del and G551D CFTR, respectively.
    • $54
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    653-47
    T88891224678-75-4
    653-47 acts as a potentiator significantly enhancing the inhibitory activity of 666-15 on the cAMP-response element binding protein (CREB), while it also exhibits mild CREB inhibitory properties itself, with an IC50 value of 26.3 μM [1].
    • $937
    1-2 weeks
    Size
    QTY
    Ivacaftor hydrate
    T13742L1134822-07-3
    Ivacaftor hydrate is an orally bioavailable CFTR potentiator. It also is used for cystic fibrosis treatment.
    • $1,520
    1-2 weeks
    Size
    QTY
    5-MPEP
    T71975124300-38-5
    5-MPEP is a neutral allosteric site ligand of the metabotropic glutamate receptor subtype 5 (mGlu5), blocking the effects of both the allosteric antagonist MPEP and potentiator CDPPB.
    • $1,520
    6-8 weeks
    Size
    QTY
    LY 2087101
    T22939913186-74-0
    Allosteric potentiator of α7, α4β2 and α4β4 nAChRs
    • $588
    35 days
    Size
    QTY
    Galanthamine hydrobromide
    T00861953-04-4
    Galanthamine hydrobromide (Galantamine hydrobromide), a long-acting and centrally active AChE inhibitor (IC50:410 nM), is an allosteric potentiator at neuronal nicotinic ACh receptors.
    • $36
    In Stock
    Size
    QTY
    Mibampator
    T15820375345-95-2
    Mibampator (LY451395) is an effective and selective AMPA receptor potentiator.
    • $31
    In Stock
    Size
    QTY
    HUHS2002
    T255081393102-59-4
    HUHS2002 is a free fatty acid derivative that works as a potentiator of GluA1 AMPA receptor responses and α7 ACh receptor responses.
    • $1,520
    6-8 weeks
    Size
    QTY
    Cyclothiazide
    T45732259-96-3
    Cyclothiazide is a benzothiadiazide that acts as a potentiator of AMPA receptorsthat potently inhibits AMPA receptor desensitization, positively modulating its response to glutamic acid (EC50 = 3.8 M).
    • $34
    In Stock
    Size
    QTY
    SBI-0061869
    T24766853760-12-0
    SBI-0061869 is a potentiator of metabotropic glutamate receptors. It was used against neurological and psychiatric disorders.
    • $1,520
    6-8 weeks
    Size
    QTY
    653-47 hydrochloride
    T88901224567-46-7
    653-47 hydrochloride is a potentiator, significantly potentiates the cAMP-response element binding protein (CREB) inhibitory activity of 666-15. It is also a very weak CREB inhibitor with IC50 of 26.3 μM.
    • $84
    In Stock
    Size
    QTY
    AM-1488
    T616552079895-60-4
    AM1488 is a potent, orally active glycine receptor ( GlyR ) potentiator (hGlyRα3 EC 50 =0.45 μM) [1] [2].
    • $2,140
    6-8 weeks
    Size
    QTY
    NSC339614 potassium
    T245511135037-53-4
    NSC339614 potassium is a selective GluN1/GluN2C and GluN1/GluN2D receptors potentiator.
    • $1,520
    6-8 weeks
    Size
    QTY
    VU0152099
    T29123612514-42-8
    VU0152099 is a potent and selective M4 mAChR allosteric potentiator(EC50 = 380 ± 93 nM).
    • $47
    In Stock
    Size
    QTY
    DNAC-1
    T240101006021-30-2
    DNAC-1 is against Gram-positive and Gram-negative pathogens potentiator of β-lactam activity.
    • $1,520
    6-8 weeks
    Size
    QTY
    S07-2001
    T610331197904-57-6
    S07-2001 enhances Doxorubicin against cancer cells activity, which can be used as a chemotherapeutic potentiator for cancer drug resistance. S07-2001 is a potent and selective inhibitor of aldo-keto reductase 1C3 (AKR1C3) with an IC 50 value of 2.08 μM [1].
    • $1,520
    6-8 weeks
    Size
    QTY
    UBP646
    T249161333213-35-6
    UBP646 is a GluN1/GluN2 receptors potentiator.
    • $1,520
    6-8 weeks
    Size
    QTY
    Biphenylindanone A
    T14615866823-73-6
    Biphenylindanone A is a selective potentiator of human mGluR2 (hmGluR2),and for the treatment of neurological disorders.
    • $265
    35 days
    Size
    QTY
    LY2607540
    T279351204737-09-6
    LY2607540 is a metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties (EC(50) = 23 and 13 nM, respectively).
    • $1,520
    6-8 weeks
    Size
    QTY
    CP-628006
    T40386305822-08-6
    CP-628006 is a small molecule CFTR potentiator that effectively restores ATP-dependent channel gating to G551D-CFTR, the mutant form found in cystic fibrosis.
    • $1,520
    Backorder
    Size
    QTY
    Polygodial
    T231726754-20-7
    Polygodial (Tadeonal) is an antifungal potentiator and an antibiotic, particularly against Saccharomyces cerevisiae, Candida utilis, and Sclerotinia libertiana.
    • $84
    In Stock
    Size
    QTY
    LY503430
    T27959625820-83-9
    LY503430 is a AMPA receptor potentiator with oral activity. LY503430 has both nootropic and neuroprotective effects, reducing brain damage caused by 6-hydroxydopamine or MPTP.
    • $2,420
    10-14 weeks
    Size
    QTY
    KRAS G13D peptide, 25 mer
    T38936145019-94-9
    KRAS G13D peptide, a 25-mer sequence, is derived from the KRAS activating oncogene mutation and serves as an immune potentiator. This peptide possesses immunogenic properties and can be utilized for the development of a KRAS vaccine.
    • Inquiry Price
    Size
    QTY
    DETQ
    T738231638667-81-8
    DETQ, a selective, allosteric, and orally active potentiator of the dopamine D1 receptor (Dopamine Receptor), enhances cAMP production in HEK293 cells expressing the human D1 receptor, achieving an EC50 of 5.8 nM and a K b of 26 nM. It demonstrates approximately 30-fold reduced potency at rat and mouse D1 receptors and shows no activity at the human D5 receptor [1].
    • Inquiry Price
    Size
    QTY
    PD 81723
    T23130132861-87-1
    Allosteric potentiator at the adenosine A1 receptor
    • $488
    35 days
    Size
    QTY
    EOS-62062
    T46671258963-59-5
    Pesampator (PF-04958242) is a potent, highly selective positive allosteric modulator of the AMPA receptor, also known as an AMPA potentiator, demonstrating an EC50 of 310 nM and a Ki of 170 nM [1].
      7-10 days
      Inquiry